Abstract | UNLABELLED:
Cyclosporine is highly effective in the treatment of a multitude of dermatoses. Concern over its side effect profile has limited its use in dermatology. Adverse effects are, for the most part, dose dependent and related to duration of therapy. Using the recommended monitoring protocols results in a significant decrease in the incidence of cyclosporine-related toxicities. This article provides a comprehensive review of the pharmacokinetics of cyclosporine, potential drug interactions, adverse effects, and recommendations for monitoring in patients treated with cyclosporine. The use of cyclosporine in pregnancy and in the pediatric population is also addressed. LEARNING OBJECTIVES: After completing this learning activity, participants should be familiar with the monitoring guidelines of cyclosporine, its contraindications, its possible drug interactions, its adverse effect profile, and its use in pregnancy and the childhood and adolescent populations.
|
Authors | Caitriona Ryan, Karrie T Amor, Alan Menter |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 63
Issue 6
Pg. 949-72; quiz 973-4
(Dec 2010)
ISSN: 1097-6787 [Electronic] United States |
PMID | 21093660
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved. |
Chemical References |
- Dermatologic Agents
- Cyclosporine
|
Topics |
- Child
- Cyclosporine
(pharmacokinetics, therapeutic use)
- Dermatologic Agents
(pharmacokinetics, therapeutic use)
- Dermatology
- Education, Medical, Continuing
- Female
- Humans
- Pediatrics
- Pregnancy
- Pregnancy Complications
(drug therapy)
- Skin Diseases
(drug therapy)
|